Sandler Capital Management Pfizer Inc Transaction History

Sandler Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $227,552 - $277,784	5,200 New	5,200 $228,000
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $200,812 - $227,896	-6,100 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $168,750 - $185,400	-4,500 Reduced 42.45%	6,100 $259,000
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $534,733 - $609,654	-13,900 Reduced 56.73%	10,600 $463,000
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $258,525 - $313,575	-7,500 Reduced 23.44%	24,500 $1.08 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $992,000 - $1.09 Million	32,000	32,000 $1.14 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Sandler Capital Management, based on Form 13F filings with the SEC.

Stay updated on Sandler Capital Management with notifications on news.